Preconception care: Preventing and treating infections

Reproductive Health

Volumn 11, Issue , 2014, Pages

  Lassi, Zohra S ^a   Imam, Ayesha M ^a   Dean, Sohni V ^a   Bhutta, Zulfiqar A ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

HIV; infection; preconception; Sexually transmitted infections

Indexed keywords

PLACEBO; TETANUS TOXOID;

ARTICLE; CONDOM USE; CYTOMEGALOVIRUS INFECTION; DENTAL CARIES; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; MATERNAL CARE; META ANALYSIS; NEWBORN DEATH; PERIODONTAL DISEASE; SEXUALLY TRANSMITTED DISEASE; SYSTEMATIC REVIEW; TETANUS; FEMALE; HIV INFECTIONS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROCEDURES; SEXUALLY TRANSMITTED DISEASES; VACCINATION;

FEMALE; HIV INFECTIONS; HUMANS; PRECONCEPTION CARE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SEXUALLY TRANSMITTED DISEASES; VACCINATION;

EID: 84907441047     PISSN: None     EISSN: 17424755     Source Type: Journal    
DOI: 10.1186/1742-4755-11-S3-S4     Document Type: Article

References (156)

1. The need and plan for global elimination of congenital syphilis. Schmid GP, Stoner BP, Hawkes S, Broutet N, Sex Transm Dis 2007 34 7 5 S10
2. Report on the global HIV/AIDS epidemic. Joint United Nations Programme on HA Unaids, Joint United Nations Programme on HIV/AIDS 2008
3. UNAIDS report on the global AIDS epidemic. UNAIDS, 2010 Available on http://www.unaids.org/globalreport/Global-report.htm [accessed on March 2013]
4. UNAIDS report on the global AIDS epidemic. UNAIDS, 2010 Available on http://www.unaids.org/globalreport/Global-report.htm [accessed on March 2013]
5. Sexual behavior and pregnancy outcome in HIV-infected women. Hankins C, Tran T, Lapointe N, JAIDS Journal of Acquired Immune Deficiency Syndromes 1998 18 5 479
6. Association of maternal HIV infection with low birth weight. Markson LE, Turner BJ, Houchens R, Silverman NS, Cosler L, Takyi BK, JAIDS Journal of Acquired Immune Deficiency Syndromes 1996 13 3 227
7. Infection with HIV as a risk factor for adverse obstetrical outcome. Temmerman M, Plummer FA, Mirza NB, Ndinya-Achola JO, Wamola IA, Nagelkerke N, Brunham RC, Piot P, Aids 1990 4 11 1087
8. Incidence of premature birth and neonatal respiratory disease in infants of HIV-positive mothers. Martin R, Boyer P, Hammill H, Peavy H, Platzker A, Settlage R, Shah A, Sperling R, Tuomala R, Wu M, The Journal of pediatrics 1997 131 6 851 856
9. HIV/AIDS Surveillance Report. Centers for Disease Control and Prevention, 1998 10 1 40
10. the Study Group for the Medical Research Council Collaborative Study of Women with HIV. The effect of HIV diagnosis on reproductive experience. Stephenson JM, Griffioen A, Aids 1996 10 14 1683 1687
11. Reproductive choices among HIV-positive women. Bedimo AL, Bessinger R, Kissinger P, Social Science & Medicine 1998 46 2 171 179
12. HIV infection and sexually transmitted diseases. Over M, Piot P, Disease control priorities in developing countries 1993
13. Sexually transmitted infections among Nigerian adolescent schoolgirls. Ikimalo J, Obunge OK, Babatunde S, Ikokwu-Wonodi C, Briggs ND, Kemp J, Dollimore N, Brabin L, Agbaje O, Hart CA, British Medical Journal 1999 75 2 121
14. Condom use and correlates of African American adolescent females' infrequent communication with sex partners about preventing sexually transmitted diseases and pregnancy. Crosby RA, DiClemente RJ, Wingood GM, Cobb BK, Harrington K, Davies SL, Hook EW, Oh MK, Health Education & Behavior 2002 29 2 219
15. The hidden epidemic: confronting sexually transmitted diseases. Eng TR, Butler WT, National Academies 1997
16. Exposure to human immunodeficiency virus among healthcare workers in South Africa. Gounden YP, Moodley J, International Journal of Gynecology & Obstetrics 2000 69 3 265 270
17. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. Laga M, Manoka A, Kivuvu M, Malele B, Tuliza M, Nzila N, Goeman J, Behets F, Batter V, Alary M, Aids 1993 7 1 95
18. Setting research priorities for preconception care in low-and middle-income countries: aiming to reduce maternal and child mortality and morbidity. Dean S, Rudan I, Althabe F, Girard AW, Howson C, Langer A, Lawn J, Reeve M-E, Teela KC, Toledano M, PLoS Med 2013 10 9 1001508
19. Meeting to develop a global consensus on preconception care to reduce maternal and childhood mortality and morbidity. WHO WHO, Geneva: World Health Organization Headquarters 2012
20. Preconception Care: closing the gap in the continuum of care to accelerate improvements in maternal, newborn and child health. Dean SV, Lassi ZS, Imam AM, Bhutta ZA, Reproductive Health 2014
21. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.0 [updated February 2008]. The Cochrane Collaboration, Higgins JPT, Green S, 2008 Available from http://www.cochranehandbook.org
22. Editorial: standards of reporting: the CONSORT, QUORAM, and STROBE guidelines. Brand RA, Clin Orthop Relat Res 2009 467 6 1393 1394
23. Review Manager (RevMan). [computer program]. Version 5.0: Copenhagen: Nordic Cochrane Collaboration 2008
24. Preconception care: promoting reproductive planning. Dean SV, Lassi ZS, Imam AM, Bhutta ZA, Reproductive Health 2014
25. Syndromic management of sexually-transmitted infections and behaviour change interventions on transmission of HIV-1 in rural Uganda: a community randomised trial. Kamali A, Quigley M, Nakiyingi J, Kinsman J, Kengeya-Kayondo J, Gopal R, Ojwiya A, Hughes P, Carpenter LM, Whitworth J, The Lancet 2003 361 9358 645 652
26. Improved treatment services significantly reduce the prevalence of sexually transmitted diseases in rural Tanzania: results of a randomized controlled trial. Mayaud P, Mosha F, Todd J, Balira R, Mgara J, West B, Rusizoka M, Mwijarubi E, Gabone R, Gavyole A, Aids 1997 11 15 1873
27. Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Wawer MJ, Sewankambo NK, Serwadda D, Quinn TC, Paxton LA, Kiwanuka N, Wabwire-Mangen F, Li C, Lutalo T, Nalugoda F, The Lancet 1999 353 9152 525 535
28. Impact of Pre-Conception Health Care: Evaluation of a Social Determinants Focused Intervention. Livingood W, Brady C, Pierce K, Atrash H, Hou T, Bryant T, Maternal and child health journal 2010 14 3 382 391
29. Patient-delivered partner treatment with azithromycin to prevent repeated Chlamydia trachomatis infection among women: a randomized, controlled trial. Schillinger J, Kissinger P, Calvet H, et al. Sexually Transmitted Diseases 2003 30 1 49
30. Group counseling to prevent sexually transmitted disease and HIV: a randomized controlled trial. Branson BM, Peterman TA, Cannon RO, Ransom R, Zaidi AA, Sexually Transmitted Diseases 1998 25 10 553 560
31. Sexually transmitted disease (STD) and HIV risk in heterosexual adults attending a public STD clinic: evaluation of a randomized controlled behavioral risk-reduction intervention trial. Boyer CB, Barrett DC, Peterman TA, Bolan G, Aids 1997 11 3 359 367
32. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. Kamb ML, Fishbein M, Douglas JM Jr, Rhodes F, Rogers J, Bolan G, Zenilman J, Hoxworth T, Malotte CK, Iatesta M, Jama 1998 280 13 1161
33. Prevention of gonorrhea and chlamydia through behavioral intervention: results of a two-year controlled randomized trial in minority women. Shain RN, Piper JM, Holden AEC, Champion JD, Perdue ST, Korte JE, Guerra FA, Sexually transmitted diseases 2004 31 7 401
34. A randomized, controlled trial of a behavioral intervention to prevent sexually transmitted disease among minority women. Shain RN, Piper JM, Newton ER, Perdue ST, Ramos R, Champion JD, Guerra FA, New England Journal of Medicine 1999 340 2 93
35. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Grosskurth H, Todd J, Mwijarubi E, Mayaud P, Nicoll A, The Lancet 1995 346 8974 530 536
36. Clinical course of thrombocytopenia in patients treated with imatinib mesylate for accelerated phase chronic myelogenous leukemia. van Deventer HW, Hall MD, Orlowski RZ, Mitchell BS, Berkowitz LR, Hogan C, Dunphy CH, Koehler J, Shea TC, American journal of hematology 2002 71 3 184 190
37. Impact of Thailand's HIV-control programme as indicated by the decline of sexually transmitted diseases. Hanenberg RS, Sokal DC, Rojanapithayakorn W, Kunasol P, Lancet 1994 344 8917 243 245
38. Consultation on Antiretroviral Treatment for Prevention of HIV Transmission. Meeting Report. WHO, Geneva, Switzerland 2009
39. Sexual risk reduction interventions do not inadvertently increase the overall frequency of sexual behavior: a meta-analysis of 174 studies with 116,735 participants. Smoak ND, Scott-Sheldon LAJ, Johnson BT, Carey MP, Journal of acquired immune deficiency syndromes (1999) 2006 41 3 374
40. Highly active antiretroviral therapy and sexual risk behavior. Crepaz N, Hart TA, Marks G, JAMA: The Journal of the American Medical Association 2004 292 2 224
41. Use of postexposure prophylaxis against HIV infection following sexual exposure does not lead to increases in high-risk behavior. Martin JN, Roland ME, Neilands TB, Krone MR, Bamberger JD, Kohn RP, Chesney MA, Franses K, Kahn JO, Coates TJ, Aids 2004 18 5 787
42. Evidence for the effects of VCT on behaviour. Higgins D, JAMA 1991 266 2419 2429
43. The impact of HIV treatment on risk behaviour in developing countries: a systematic review. Kennedy C, O Reilly K, Medley A, Sweat M, AIDS care 2007 19 6 707 720
44. Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda. Bunnell R, Ekwaru JP, Solberg P, Wamai N, Bikaako-Kajura W, Were W, Coutinho A, Liechty C, Madraa E, Rutherford G, Aids 2006 20 1 85
45. Periconception pre-exposure prophylaxis to prevent HIV transmission: benefits, risks, and challenges to implementation. Matthews LT, Baeten JM, Celum C, Bangsberg DR, AIDS 2010 24 13 1975
46. Tenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled trial. Peterson L, Taylor D, Roddy R, Belai G, Phillips P, Nanda K, Grant R, Clarke EEK, Doh AS, Ridzon R, PLoS Hub for Clinical Trials 2007 2 5 27
47. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A, PLoS Medicine 2005 2 11 1112
48. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, Williams CFM, Campbell RT, Ndinya-Achola JO, The Lancet 2007 369 9562 643 656
49. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, Kiwanuka N, Moulton LH, Chaudhary MA, Chen MZ, The Lancet 2007 369 9562 657 666
50. Circumcision in HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial. Wawer MJ, Makumbi F, Kigozi G, Serwadda D, Watya S, Nalugoda F, Buwembo D, Ssempijja V, Kiwanuka N, Moulton LH, The Lancet 2009 374 9685 229 237
51. Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis. Weiss HA, Quigley MA, Hayes RJ, Aids 2000 14 15 2361
52. Safety and effectiveness of vaginal microbicides BufferGel and 0.5% PRO 2000/5 gel for the prevention of HIV infection in women: results of the HPTN 035 trial. Karim SA, Coletti A, Richardson B, Ramjee G, Hoffman I, Chirenje M, Taha T, Kapina M, Maslankowski L, Soto-Torres L, 2009 8 11
53. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, Kharsany A, Sibeko S, Mlisana KP, Omar Z, Science 2010 329 5996 1168
54. PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial. McCormack S, Ramjee G, Kamali A, Rees H, Crook AM, Gafos M, Jentsch U, Pool R, Chisembele M, Kapiga S, The Lancet 2010 376 9749 1329 1337
55. Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. Skoler-Karpoff S, Ramjee G, Ahmed K, Altini L, Plagianos MG, Friedland B, Govender S, De Kock A, Cassim N, Palanee T, The Lancet 2008 372 9654 1977 1987
56. HIV incidence and sexually transmitted disease prevalence associated with condom use: a population study in Rakai, Uganda. Ahmed S, Lutalo T, Wawer M, Serwadda D, Sewankambo NK, Nalugoda F, Makumbi F, Wabwire-Mangen F, Kiwanuka N, Kigozi G, Aids 2001 15 16 2171
57. The effectiveness of condoms in reducing heterosexual transmission of HIV. Davis KR, Weller SC, Family Planning Perspectives 1999 31 6 272 279
58. Effectiveness of condoms in preventing HIV transmission. Pinkerton SD, Abramson PR, Social Science & Medicine 1997 44 9 1303 1312
59. Condom effectiveness in reducing heterosexual HIV transmission. Weller S, Davis K, Cochrane Database Syst Rev 2002 1 1 22
60. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Padian NS, van der Straten A, Ramjee G, Chipato T, de Bruyn G, Blanchard K, Shiboski S, Montgomery ET, Fancher H, Cheng H, The Lancet 2007 370 9583 251 261
61. Efficacy of voluntary HIV-1 counselling and testing in individuals and couples in Kenya, Tanzania, and Trinidad: a randomised trial. Coates TJ, Lancet 2000 356 9224 103 112
62. HIV voluntary counseling and testing and behavioral risk reduction in developing countries: a meta-analysis, 1990-2005. Denison JA, O'Reilly KR, Schmid GP, Kennedy CE, Sweat MD, AIDS and Behavior 2008 12 3 363 373
63. Mass media interventions for promoting HIV testing. Vidanapathirana J, Abramson MJ, Forbes A, Fairley C, Cochrane database of systematic reviews (Online) 2005 3 D004775
64. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. Celum C, Wald A, Lingappa JR, Magaret AS, Wang RS, Mugo N, Mujugira A, Baeten JM, Mullins JI, Hughes JP, New England journal of medicine 2010 362 5 427 439
65. Evaluation of an abstinence-based curriculum for early adolescents: First year changes in sex attitudes, knowledge, and behavior. Goldfarb E, Donnelly J, Duncan DF, Young M, Eadie C, Castiglia D, North American Journal of Psychology 1999 1 243 254
66. Abstinence and safer sex HIV risk-reduction interventions for African American adolescents. Jemmott JB, Jemmott LSweet, Fong GT, JAMA: The Journal of the American Medical Association 1998 279 19 1529
67. Impacts of four Title V, Section 510 abstinence education programs. Trenholm C, Devaney B, Fortson K, Quay L, Wheeler J, Clark M, Princeton, NJ: Mathematica Policy Research, Inc 2007
68. A STD/HIV prevention trial among adolescents in managed care. Boekeloo BO, Schamus LA, Simmens SJ, Cheng TL, O'Connor K, D'Angelo LJ, Pediatrics 1999 103 1 107
69. Keepin'it REAL!: Results of a mother-adolescent HIV prevention program. DiIorio C, Resnicow K, McCarty F, De AK, Dudley WN, Wang DT, Denzmore P, Nursing research 2006 55 1 43
70. The impact of the Postponing Sexual Involvement curriculum among youths in California. Kirby D, Korpi M, Barth RP, Cagampang HH, Family Planning Perspectives 1997 29 3 100 108
71. The national evaluation of the Children's Aid Society Carrera-Model Program to prevent teen pregnancy. Philliber S, Kaye J, Herrling S, Accord, NY: Philliber Research Associates 2001
72. Outcomes of a randomized, controlled community-level HIV prevention intervention for adolescents in low-income housing developments. Sikkema KJ, Anderson ES, Kelly JA, Winett RA, Gore-Felton C, Roffman RA, Heckman TG, Graves K, Hoffmann RG, Brondino MJ, Aids 2005 19 14 1509
73. A randomized, controlled effectiveness trial of an AIDS prevention program for low-income African-American youths. Stanton BF, Xiaoming LI, Ricardo I, Galbraith J, Feigelman S, Kaljee L, Archives of pediatrics & adolescent medicine 1996 150 4 363 372
74. Trial of an urban adolescent sexual risk-reduction intervention for rural youth: a promising but imperfect fit. Stanton B, Harris C, Cottrell L, Li X, Gibson C, Guo J, Pack R, Galbraith J, Pendleton S, Wu Y, Journal of Adolescent Health 2006 38 1 55 e25-55. e36
75. Does parental involvement make a difference? The impact of parent interactive activities on students in a school-based AIDS prevention program. Weeks K, Levy SR, Gordon AK, Handler A, Perhats C, Flay BR, AIDS education and prevention 1997 9 1 90 106
76. Sustaining and broadening intervention impact: a longitudinal randomized trial of 3 adolescent risk reduction approaches. Wu Y, Stanton BF, Galbraith J, Kaljee L, Cottrell L, Li X, Harris CV, D'Alessandri D, Burns JM, Pediatrics 2003 111 1 32
77. The efficacy of behavioral interventions in reducing HIV risk sex behaviors and incident sexually transmitted disease in black and Hispanic sexually transmitted disease clinic patients in the United States: A meta-analytic review. Crepaz N, Horn AK, Rama SM, Griffin T, Deluca JB, Mullins MM, Aral SO, Sexually Transmitted Diseases 2007 34 6 319
78. Prevalence of unprotected anal intercourse among HIV-diagnosed MSM in the United States: a meta-analysis. Crepaz N, Marks G, Liau A, Mullins MM, Aupont LW, Marshall KJ, Jacobs ED, Wolitski RJ, Aids 2009 23 13 1617
79. The efficacy of behavioral interventions in reducing HIV risk behaviors and incident sexually transmitted diseases in heterosexual African Americans. Darbes L, Crepaz N, Lyles C, Kennedy G, Rutherford G, Aids 2008 22 10 1177
80. Substitution treatment of injecting opioid users for prevention of HIV infection (Review). Gowing L, Farrell M, Bornemann R, Sullivan LE, Ali R, 2008
81. Efficacy of HIV prevention interventions in Latin American and Caribbean Nations, 1995-2008: a meta-analysis. Huedo-Medina TB, Boynton MH, Warren MR, LaCroix JM, Carey MP, Johnson BT, AIDS and Behavior 2010 1 15
82. Behavioral Interventions for African-Americans to Reduce Sexual Risk of HIV: A Meta-Analysis of Randomized Controlled Trials. Johnson BT, Scott-Sheldon LAJ, Smoak ND, LaCroix JM, Anderson JR, Carey MP, Journal of acquired immune deficiency syndromes (1999) 2009 51 4 492
83. Behavioural interventions for HIV positive prevention in developing countries: a systematic review and meta-analysis. Kennedy CE, Medley AM, Sweat MD, O'Reilly KR, Bulletin of the World Health Organization 2010 88 8 615 623
84. Is care and support associated with preventive behaviour among people with HIV? MacNeil JM, Mberesero F, Kilonzo G, AIDS care 1999 11 5 537 546
85. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. Marks G, Crepaz N, Janssen RS, Aids 2006 20 10 1447
86. Review and meta-analysis of HIV prevention intervention research for heterosexual adult populations in the United States. Neumann MS, Johnson WD, Semaan S, Flores SA, Peersman G, Hedges LV, Sogolow E, JAIDS Journal of Acquired Immune Deficiency Syndromes 2002 30 106
87. Behavioral interventions to reduce HIV-related sexual risk behavior: Review and synthesis of meta-analytic evidence. Noar SM, AIDS and Behavior 2008 12 3 335 353
88. A meta-analysis of the effect of HIV prevention interventions on the sex behaviors of drug users in the United States. Semaan S, Des Jarlais DC, Sogolow E, Johnson WD, Hedges LV, Ramirez G, Flores SA, Norman L, Sweat MD, Needle R, JAIDS Journal of Acquired Immune Deficiency Syndromes 2002 30 73
89. A profile of US-based trials of behavioral and social interventions for HIV risk reduction. Semaan S, Kay L, Strouse D, Sogolow E, Mullen PD, Neumann MS, Flores SA, Peersman G, Johnson WD, Lipman PD, JAIDS Journal of Acquired Immune Deficiency Syndromes 2002 30 30
90. Effectiveness of HIV prevention strategies in resource-poor countries: tailoring the intervention to the context. Wegbreit J, Bertozzi S, DeMaria LM, Padian NS, Aids 2006 20 9 1217
91. Behavioral HIV risk reduction among people who inject drugs: meta-analytic evidence of efficacy. Copenhaver MM, Johnson BT, Lee I, Journal of Substance Abuse Treatment 2006 31 2 163 171
92. A meta-analysis of needle sharing, lending, and borrowing behaviors of needle exchange program attenders. Ksobiech K, AIDS education and prevention 2003 15 3 257 268
93. Pituitary Network Connectivity as a Mechanism for the Luteinising Hormone Surge. Lyles D, Tien JH, McCobb DP, Zeeman ML, Journal of neuroendocrinology 2010 22 12 1267 1278
94. Psychosocial interventions for reducing injection and sexual risk behaviour for preventing HIV in drug users. Meader N, Li R, Des Jarlais DC, Pilling S, Cochrane database of systematic reviews (Online) 2010 1 D007192
95. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Fleming DT, Wasserheit JN, Sexually transmitted infections 1999 75 1 3
96. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. Wald A, Link K, Journal of Infectious Diseases 2002 185 1 45
97. The role of male circumcision in the prevention of human papillomavirus and HIV infection. Gray RH, Wawer MJ, Serwadda D, Kigozi G, Journal of Infectious Diseases 2009 199 1 1
98. Update of the drug resistance mutations in HIV-1: Fall 2006. Johnson VA, Brun-Vézinet F, Clotet B, Kuritzkes DR, Pillay D, Schapiro JM, Richman DD, Top HIV Med 2006 14 3 125 130
99. A two-year study of bacterial, viral, and parasitic agents associated with diarrhea in rural Bangladesh. Black RE, Merson MH, Rahman ASMM, Yunus M, Alim ARMA, Huq I, Yolken RH, Curlin GT, Journal of Infectious Diseases 1980 142 5 660 664
100. Duration of protective immunity conferred by maternal tetanus toxoid immunization: further evidence from Matlab, Bangladesh. Koenig MA, Roy NC, McElrath T, Shahidullah MD, Wojtyniak B, American Journal of Public Health 1998 88 6 903
101. The use of tetanus toxoid for the prevention of neonatal tetanus in developing countries for the prevention of tetanus neonatorum. Newell KW, Bull WHO 1966 35 863 871
102. Impact of a tetanus toxoid immunization mass campaign on neonatal tetanus mortality in Aceh Province, Indonesia. Yusuf B, Solter S, Bertsch D, Arnold RB, The Southeast Asian journal of tropical medicine and public health 1991 22 3 351
103. Fetal risk associated with rubella vaccine: an update. Bart SW, Stetler HC, Preblud SR, Williams NM, Orenstein WA, Bart KJ, Hinman AR, Herrmann KL, Review of Infectious Diseases 1985 7 Supplement 1 95
104. Rubella antibody titers in vaccinated and nonvaccinated women and results of vaccination during pregnancy. Enders G, Review of Infectious Diseases 1985 7 Supplement 1 103
105. Cost-effectiveness of different strategies for prevention of congenital rubella infection: a practical example from Iceland. Gudnadóttir M, Review of Infectious Diseases 1985 7 Supplement 1 200
106. Premarital rubella screening in Rhode Island. Lieberman E, Faich GA, Simon PR, Mullan RJ, JAMA: The Journal of the American Medical Association 1981 245 13 1333
107. Rubella antibody tests in family planning clinics. Mayon-White RT, Bull MJ, The Practitioner 1976 216 1293 317
108. Epidemiology of congenital rubella and results of rubella vaccination in Australia. Menser MA, Hudson JR, Murphy AM, Upfold LJ, Review of Infectious Diseases 1985 7 Supplement 1 37
109. Effect of selective vaccination on rubella susceptibility and infection in pregnancy. Miller CL, Miller E, Sequeira PJ, Cradock-Watson JE, Longson M, Wiseberg EC, British medical journal (Clinical research ed) 1985 291 6506 1398
110. Premarital rubella screening program: from identification to vaccination of susceptible women in the state of Hawaii. Serdula MK, Marks JS, Remington PL, Ibara CM, White MC, Public Health Reports 1986 101 3 329
111. New Mexico's premarital rubella test program. Sewell CM, Hull HF, Montes J, Ortiz A, American journal of public health 1986 76 10 1250
112. Seroprevalence of rubella among women of childbearing age in Taiwan after nationwide vaccination. Su SB, Guo HR, The American journal of tropical medicine and hygiene 2002 67 5 549
113. Premarital rubella vaccination program. Vogt RL, Clark SW, American journal of public health 1985 75 9 1088
114. Seroprevalence of rubella infection after national immunization program in Taiwan: vaccination status and immigration impact. Wang I, Journal of medical virology 2007 79 1 97 103
115. Pregnancy Outcomes From the Pregnancy Registry of a Human Papillomavirus Type6/11/16/18 Vaccine. Dana A, Buchanan KM, Goss MA, Seminack MM, Shields KE, Korn S, Cunningham ML, Haupt RM, Obstetrics & Gynecology 2009 114 6 1170
116. Control of neonatal tetanus in southern Thailand. Chongsuvivatwong V, Bujakorn L, Kanpoy V, Treetrong R, International Journal of Epidemiology 1993 22 5 931
117. Vaccines for women to prevent neonatal tetanus. Demicheli V, Barale A, Rivetti A, 2008 2 status and date: Edited (no change to conclusions)
118. Pregnancy outcome following rubella vaccination: a prospective controlled study. Bar Oz B, Levichek Z, Moretti ME, Mah C, Andreou S, Koren G, American Journal of Medical Genetics Part A 2004 130 1 52 54
119. Congenital rubella syndrome after rubella vaccination in 1-4 weeks periconceptional period. Nasiri R, Yoseffi J, Khajedaloe M, Sarafraz Yazdi M, Delgoshaei F, Indian journal of pediatrics 2009 76 3 279 282
120. Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trials. Wacholder S, Chen BE, Wilcox A, Macones G, Gonzalez P, Befano B, Hildesheim A, Rodríguez AC, Solomon D, Herrero R, BMJ: British Medical Journal 2010 340
121. Pregnancy and infant outcomes in the clinical trials of a human papillomavirus type 6/11/16/18 vaccine: a combined analysis of five randomized controlled trials. Garland SM, Ault KA, Gall SA, Paavonen J, Sings HL, Ciprero KL, Saah A, Marino D, Ryan D, Radley D, Obstetrics & Gynecology 2009 114 6 1179
122. The preterm prediction study: fetal fibronectin, bacterial vaginosis, and peripartum infection. Goldenberg RL, Thom E, Moawad AH, Johnson F, Roberts J, Caritis SN, Obstetrics & Gynecology 1996 87 5 Part 1 656
123. Periodontal infection as a possible risk factor for preterm low birth weight. Offenbacher S, Katz V, Fertik G, Collins J, Boyd D, Maynor G, McKaig R, Beck J, Journal of periodontology 1996 67 10s 1103 1113
124. Exploring the relationship between periodontal disease and pregnancy complications. Bobetsis YA, Barros SP, Offenbacher S, The Journal of the American Dental Association 2006 137 2 7S
125. Periodontal disease as a risk factor for adverse pregnancy outcomes. A systematic review. Scannapieco FA, Bush RB, Paju S, Annals of Periodontology 2003 8 1 70 78
126. Periodontal infection and adverse pregnancy outcomes: a systematic review of epidemiological studies. Vettore MV, Lamarca GA, Leão ATT, Thomaz FB, Sheiham A, Leal MC, Cadernos de Saúde Pública 2006 22 10 2041 2053
127. Periodontal disease and adverse pregnancy outcomes: a systematic review. Xiong X, Buekens P, Fraser WD, Beck J, Offenbacher S, BJOG: An International Journal of Obstetrics & Gynaecology 2006 113 2 135 143
128. Periodontal diseases and the risk of preterm birth and low birth weight: a meta-analysis. Khader YS, Ta'ani Q, Journal of periodontology 2005 76 2 161 165
129. Preterm low birth weight and maternal periodontal status: a meta-analysis. Vergnes JN, Sixou M, American journal of obstetrics and gynecology 2007 196 2 135 e131-135. e137
130. Periodontal disease and pregnancy outcomes: state-of-the-science. Xiong X, Buekens P, Vastardis S, Yu SM, Obstetrical & gynecological survey 2007 62 9 605
131. Effect of periodontal disease treatment during pregnancy on preterm birth incidence: a metaanalysis of randomized trials. Polyzos NP, Polyzos IP, Mauri D, Tzioras S, Tsappi M, Cortinovis I, Casazza G, American journal of obstetrics and gynecology 2009 200 3 225 232
132. Oral Health and Adverse Pregnancy Outcomes-What's Next? Han YW, Journal of Dental Research 2011 90 3 289
133. A critical assessment of adverse pregnancy outcome and periodontal disease. Wimmer G, Pihlstrom BL, Journal of clinical periodontology 2008 35 380 397
134. Periodontal disease and bacterial vaginosis increase the risk for adverse pregnancy outcome. Oittinen J, Kurki T, Kekki M, Kuusisto M, Pussinen P, Vilkuna-Rautiainen T, Nieminen A, Asikainen S, Paavonen J, Infectious Diseases in Obstetrics and Gynecology 2005 13 4 213 216
135. An Examination of Periodontal Treatment, Dental Care, and Pregnancy Outcomes in an Insured Population in the United States. Albert DA, Begg MD, Andrews HF, Williams SZ, Ward A, Lee Conicella M, Rauh V, Thomson JL, Papapanou PN, American journal of public health 2011 101 1 151
136. Congenital cytomegalovirus infection-a question of screening. Rahav G, IMAJ-RAMAT GAN- 2007 9 5 392
137. Diagnosis and outcome of preconceptional and periconceptional primary human cytomegalovirus infections. Revello MG, Zavattoni M, Furione M, Lilleri D, Gorini G, Gerna G, Journal of Infectious Diseases 2002 186 4 553
138. Cytomegalovirus seroconversion rates and risk factors: implications for congenital CMV. Hyde TB, Schmid DS, Cannon MJ, Reviews in Medical Virology 2010
139. Prevention of maternal cytomegalovirus infection: current status and future prospects. Nyholm JL, Schleiss MR, International journal of women's health 2010 2 23
140. Fetal effects of primary and secondary cytomegalovirus infection in pregnancy. Ornoy A, Diav-Citrin O, Reproductive Toxicology 2006 21 4 399 409
141. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. Boppana SB, Rivera LB, Fowler KB, Mach M, Britt WJ, Obstetrical & gynecological survey 2001 56 10 611
142. Maternal immunity and prevention of congenital cytomegalovirus infection. Fowler KB, Stagno S, Pass RF, JAMA: The Journal of the American Medical Association 2003 289 8 1008
143. Preconceptional immunity to cytomegalovirus and the risk of symptomatic congenital infection. Shaamash AH, Mohamed IS, Hasan MA, Ibrahim MA, International Journal of Gynecology & Obstetrics 2003 83 2 199 201
144. Pre and periconceptional primary cytomegalovirus infection: risk of vertical transmission and congenital disease. Daiminger A, Bäder U, Enders G, BJOG: An International Journal of Obstetrics & Gynaecology 2005 112 2 166 172
145. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Revello MG, Gerna G, Clinical microbiology reviews 2002 15 4 680
146. Interval between births and risk of congenital cytomegalovirus infection. Fowler KB, Stagno S, Pass RF, Clinical infectious diseases 2004 38 7 1035
147. Review and meta analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Kenneson A, Cannon MJ, Reviews in Medical Virology 2007 17 4 253 276
148. Preconceptional primary human cytomegalovirus infection and risk of congenital infection. Revello MG, Zavattoni M, Furione M, Fabbri E, Gerna G, Journal of Infectious Diseases 2006 193 6 783
149. Periconceptional cytomegalovirus infection: pregnancy outcome and rate of vertical transmission. Hadar E, Yogev Y, Melamed N, Chen R, Amir J, Pardo J, Prenatal diagnosis 2010
150. Secondary cytomegalovirus infection can cause severe fetal sequelae despite maternal preconceptional immunity. Zalel Y, Gilboa Y, Berkenshtat M, Yoeli R, Auslander R, Achiron R, Goldberg Y, Ultrasound in Obstetrics and Gynecology 2008 31 4 417 420
151. Condom use and risk of gonorrhea and Chlamydia: a systematic review of design and measurement factors assessed in epidemiologic studies. Warner L, Stone KM, Macaluso M, Buehler JW, Austin HD, Sexually transmitted diseases 2006 33 1 36 51
152. The effectiveness and cost-effectiveness of behavioural interventions for the prevention of sexually transmitted infections in young people aged 13-19: a systematic review and economic evaluation. Shepherd J, Kavanagh J, Picot J, Cooper K, Harden A, Barnett-Page E, Health Technology Assessment 2010 14 7 1 230
153. Effectiveness of condoms in preventing sexually transmitted infections. Holmes KK, Levine R, Weaver M, Bulletin of the World Health Organization 2004 82 6 454 461
154. Reproductive counselling for HIV-discordant couples. Semprini AE, Fiore S, Pardi G, Lancet 1997 349 9062 1401 1401
155. Effectiveness of HIV prevention for youth in sub-Saharan Africa: systematic review and meta-analysis of randomized and nonrandomized trials. Michielsen K, Chersich MF, Luchters S, De Koker P, Van Rossem R, Temmerman M, Aids 2010 24 8 1193
156. Regression of fetal cerebral abnormalities by primary cytomegalovirus infection following hyperimmunoglobulin therapy. Nigro G, Torre RL, Pentimalli H, Taverna P, Lituania M, de Tejada BM, Adler SP, Prenatal diagnosis 2008 28 6 512 517